Dual antiplatelet therapy duration after drug-eluting stents: how long?

被引：7
作者：
Helft, Gerard [1 ,2 ]
机构：
[1] Univ Paris 06, AP HP, Pitie Salpetriere Hosp, Inst Cardiol, Paris, France
[2] IHU, Inst Cardiometab & Nutr, Paris, France
来源：
JOURNAL OF THORACIC DISEASE | 2016年 / 8卷 / 08期
关键词：
IMPLANTATION; METAANALYSIS; CLOPIDOGREL; MORTALITY; EFFICACY; PAIRWISE; SAFETY;
D O I：
10.21037/jtd.2016.07.45
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：E844 / E846
页数：3
相关论文
共 19 条
  • [1] Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
    Bittl, John A.
    Baber, Usman
    Bradley, Steven M.
    Wijeysundera, Duminda N.
    [J]. CIRCULATION, 2016, 134 (10) : E156 - E178
  • [2] Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial
    Collet, Jean-Philippe
    Silvain, Johanne
    Barthelemy, Olivier
    Range, Gregoire
    Cayla, Guillaume
    Van Belle, Eric
    Cuisset, Thomas
    Elhadad, Simon
    Schiele, Francois
    Lhoest, Nicolas
    Ohlmann, Patrick
    Carrie, Didier
    Rousseau, Helene
    Aubry, Pierre
    Monsegu, Jacques
    Sabouret, Pierre
    O'Connor, Stephen A.
    Abtan, Jeremie
    Kerneis, Mathieu
    Saint-Etienne, Christophe
    Beygui, Farzin
    Vicaut, Eric
    Montalescot, Gilles
    [J]. LANCET, 2014, 384 (9954) : 1577 - 1585
  • [3] Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis
    Elmariah, Sammy
    Mauri, Laura
    Doros, Gheorghe
    Galper, Benjamin Z.
    O'Neill, Kelly E.
    Steg, Philippe Gabriel
    Kereiakes, Dean J.
    Yeh, Robert W.
    [J]. LANCET, 2015, 385 (9970) : 792 - 798
  • [4] Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents The OPTIMIZE Randomized Trial
    Feres, Fausto
    Costa, Ricardo A.
    Abizaid, Alexandre
    Leon, Martin B.
    Marin-Neto, J. Antonio
    Botelho, Roberto V.
    King, Spencer B., III
    Negoita, Manuela
    Liu, Minglei
    de Paula, J. Eduardo T.
    Mangione, Jose A.
    Meireles, George X.
    Castello, Helio J., Jr.
    Nicolela, Eduardo L., Jr.
    Perin, Marco A.
    Devito, Fernando S.
    Labrunie, Andre
    Salvadori, Decio, Jr.
    Gusmao, Marcos
    Staico, Rodolfo
    Costa, J. Ribamar
    de Castro, Juliana P.
    Abizaid, Andrea S.
    Bhatt, Deepak L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (23): : 2510 - 2522
  • [5] Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Giustino, Gennaro
    Baber, Usman
    Sartori, Samantha
    Mehran, Roxana
    Mastoris, Ioannis
    Kini, Annapoorna S.
    Sharma, Samin K.
    Pocock, Stuart J.
    Dangas, George D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (13) : 1298 - 1310
  • [6] Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial
    Helft, Gerard
    Steg, Philippe Gabriel
    Le Feuvre, Claude
    Georges, Jean-Louis
    Carrie, Didier
    Dreyfus, Xavier
    Furber, Alain
    Leclercq, Florence
    Eltchaninoff, Helene
    Falquier, Jean-Francois
    Henry, Patrick
    Cattan, Simon
    Sebagh, Laurent
    Michel, Pierre-Louis
    Tuambilangana, Albert
    Hammoudi, Nadjib
    Boccara, Franck
    Cayla, Guillaume
    Douard, Herve
    Diallo, Abdourahmane
    Berman, Emmanuel
    Komajda, Michel
    Metzger, Jean-Philippe
    Vicaut, Eric
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (04) : 365 - 374
  • [7] A New Strategy for Discontinuation of Dual Antiplatelet Therapy The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
    Kim, Byeong-Keuk
    Hong, Myeong-Ki
    Shin, Dong-Ho
    Nam, Chung-Mo
    Kim, Jung-Sun
    Ko, Young-Guk
    Choi, Donghoon
    Kang, Tae-Soo
    Park, Byoung-Eun
    Kang, Woong-Chol
    Lee, Seung-Hwan
    Yoon, Jung-Han
    Hong, Bum-Kee
    Kwon, Hyuck-Moon
    Jang, Yangsoo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (15) : 1340 - 1348
  • [8] 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
    Levine, Glenn N.
    Bates, Eric R.
    Blankenship, James C.
    Bailey, Steven R.
    Bittl, John A.
    Cercek, Bojan
    Chambers, Charles E.
    Ellis, Stephen G.
    Guyton, Robert A.
    Hollenberg, Steven M.
    Khot, Umesh N.
    Lange, Richard A.
    Mauri, Laura
    Mehran, Roxana
    Moussa, Issam D.
    Mukherjee, Debabrata
    Nallamothu, Brahmajee K.
    Ting, Henry H.
    [J]. CIRCULATION, 2011, 124 (23) : E574 - E651
  • [9] Stent thrombosis in randomized clinical trials of drug-eluting stents
    Mauri, Laura
    Hsieh, Wen-hua
    Massaro, Joseph M.
    Ho, Kalon K. L.
    D'Agostino, Ralph
    Cutlip, Donald E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (10) : 1020 - 1029
  • [10] Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
    Mauri, Laura
    Kereiakes, Dean J.
    Yeh, Robert W.
    Driscoll-Shempp, Priscilla
    Cutlip, Donald E.
    Steg, P. Gabriel
    Normand, Sharon-Lise T.
    Braunwald, Eugene
    Wiviott, Stephen D.
    Cohen, David J.
    Holmes, David R., Jr.
    Krucoff, Mitchell W.
    Hermiller, James
    Dauerman, Harold L.
    Simon, Daniel I.
    Kandzari, David E.
    Garratt, Kirk N.
    Lee, David P.
    Pow, Thomas K.
    Lee, Peter Ver
    Rinaldi, Michael J.
    Massaro, Joseph M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (23) : 2155 - 2166
12